Lithium Dose Titration Should Stop at Serum Sodium <135 mEq/L
With a serum sodium of 134 mEq/L, you should not increase the lithium dose further and should closely monitor both sodium and lithium levels, as hyponatremia increases lithium toxicity risk through reduced renal clearance.
The Critical Sodium-Lithium Interaction
Your patient is already in mild hyponatremia territory (sodium 134 mEq/L, with normal being 135-145 mEq/L). This creates a dangerous situation for lithium therapy because:
- Lithium clearance parallels sodium clearance - when sodium is low, lithium excretion decreases, leading to accumulation and potential toxicity 1
- The FDA explicitly contraindicates lithium in patients with "sodium depletion" due to very high toxicity risk 2
- Even therapeutic lithium levels (0.6-1.2 mEq/L) can become toxic when sodium is depleted 2
Why 135 mEq/L is Your Hard Stop
While the neurosurgical guideline suggests investigating hyponatremia at <131 mEq/L 3, this threshold is not applicable to your lithium patient. That guideline addresses when to treat hyponatremia in general neurosurgical populations, not when to avoid medications that worsen it.
The key principle: lithium and hyponatremia create a bidirectional toxicity risk. Lower sodium → higher lithium levels → more toxicity, even at "therapeutic" doses.
Immediate Management Steps
- Hold further lithium dose increases at sodium 134 mEq/L
- Check current lithium level - even 150 mg nightly can accumulate dangerously with impaired sodium-dependent clearance
- Assess sodium intake - ensure adequate dietary sodium (6-8 g/day) 1
- Recheck sodium in 3-5 days while maintaining current lithium dose
- Only consider dose increases if:
- Sodium normalizes to ≥135 mEq/L
- Current lithium level is subtherapeutic (<0.6 mEq/L) 4
- Patient has adequate sodium intake
Common Pitfalls to Avoid
- Don't rely solely on lithium levels - a "therapeutic" lithium level (0.6-1.2 mEq/L) can still cause toxicity in hyponatremic patients 2
- Don't assume low-dose lithium is safe - even 150 mg can accumulate when renal clearance is impaired by low sodium 1
- Watch for medication interactions - thiazides, ACE inhibitors, and ARBs all worsen both hyponatremia and lithium clearance 5
The Evidence Hierarchy
The FDA drug label 2 takes precedence here, explicitly contraindicating lithium in sodium depletion. While research suggests lithium may have effects at very low doses 6, and optimal therapeutic levels are debated (0.6-0.8 mEq/L per recent consensus 4), none of this matters if the patient cannot safely clear lithium due to hyponatremia.
The case report 1 demonstrates how sodium reduction from 6.3 to 3.0-4.0 g/day caused lithium levels to spike from 0.57-0.79 to 1.17 mEq/L on the same dose - your patient is at similar risk.
Bottom line: Sodium 134 mEq/L means stop escalating lithium. Correct the sodium first, then reassess psychiatric medication needs.